Laboratorios Farmacéuticos Rovi
GPTKB entity
Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Rovi Biotech
|
| gptkbp:advertising |
develops market strategies
|
| gptkbp:awards |
received multiple industry awards
|
| gptkbp:businessModel |
sustainable business model
pursues business expansion opportunities |
| gptkbp:CEO |
Juan_López-Belmonte
|
| gptkbp:clinicalTrials |
conducts clinical trials
conducts clinical research engages in clinical development |
| gptkbp:collaborations |
collaborates with other pharmaceutical companies
establishes clinical partnerships |
| gptkbp:community_engagement |
active in community engagement
|
| gptkbp:competitors |
conducts market research
conducts market analysis |
| gptkbp:customerBase |
diverse customer base
|
| gptkbp:customerService |
maintains high quality assurance standards
|
| gptkbp:employeeCount |
over 1,000
|
| gptkbp:financialPerformance |
strong financial performance
|
| gptkbp:focus_area |
oncology
central nervous system cardiovascular diseases infectious diseases |
| gptkbp:founded |
1946
|
| gptkbp:future_plans |
involves in strategic planning
|
| gptkbp:headquarters |
gptkb:Madrid,_Spain
|
| https://www.w3.org/2000/01/rdf-schema#label |
Laboratorios Farmacéuticos Rovi
|
| gptkbp:innovation |
focuses on innovation
|
| gptkbp:investmentFocus |
invests in new technologies
|
| gptkbp:is_part_of |
pharmaceutical industry
|
| gptkbp:market |
growing_presence_in_Latin_America
expanding_presence_in_Asia strong_market_presence_in_Europe |
| gptkbp:operates_in |
gptkb:Spain
international markets |
| gptkbp:partnerships |
various research institutions
forms strategic partnerships |
| gptkbp:patentCitation |
holds numerous patents
|
| gptkbp:philanthropy |
engages in philanthropic activities
|
| gptkbp:portfolioCompany |
diverse product portfolio
|
| gptkbp:products |
generic drugs
biopharmaceuticals focuses on product development |
| gptkbp:reach |
has a global reach
|
| gptkbp:regulatoryCompliance |
ensures regulatory compliance
obtains regulatory approvals |
| gptkbp:research |
Dr._María_García
|
| gptkbp:research_focus |
focus on innovative therapies
|
| gptkbp:researchAndDevelopment |
significant investment
|
| gptkbp:revenue |
over €300 million
|
| gptkbp:social_responsibility |
committed to corporate social responsibility.
|
| gptkbp:stockExchange |
gptkb:Madrid_Stock_Exchange
Rovi |
| gptkbp:supplyChain |
has a robust supply chain
|
| gptkbp:sustainability_initiatives |
engages in sustainability initiatives
|
| gptkbp:training |
provides employee training programs
|
| gptkbp:website |
www.rovi.es
|